At a glance · for buyers and watchdogs
Aventis Pharma Limited T/a Sanofi has won £561.9m across 11 public-sector buyers, with 9 live contracts. No active Companies House risk flags.
Why: top buyer NHS England at 100% · 100% in Medical equipment · 0 active risk flags · 0 modifications.
ESG & policies vault · 0/5
Key governance & sustainability policies. Published documents link out; missing ones are greyed.
Capabilities
What this supplier does, where they sit, who they sell to.
- NHS Framework Agreement - North of England - Tranche B
- NHS National Branded Proprietary Products (Interim Agreement) - Contracts Finder Award
- NHS Framework Agreement for Seasonal Influenza Vaccines - National
Extracted automatically from sanofi.com on Jul 2026. Not independently verified — treat as the supplier’s own marketing claims.
Case studies
Delivery stories the supplier has published, with sector and outcome.
No case studies yet
Once a claimed supplier publishes delivery stories — the buyer, the sector, what was delivered and the outcome — they appear here.
Buyer references
Named public-sector contacts who have agreed to act as a reference.
No buyer references yet
Public-sector buyers can confirm they'll act as a reference for this supplier. Confirmed references — with the contract they relate to — show here.
Accreditations & memberships
Independently issued. Verification dates cross-checked against issuer registers.
No accreditations recorded
B-Corp, ISO, Cyber Essentials, Living Wage and similar credentials appear here once added by a claimed supplier and cross-checked against the issuing register.
KPI performance
Delivery, budget and satisfaction scores reported quarterly by buyers.
No verified KPI scores yet
Once buyers report contract KPIs — delivery on time, on budget, satisfaction, adoption and accessibility — a weighted grade and breakdown appear here.
Contracts · 9 live · 7 historic
Pulled from Contracts Finder & Find a Tender. Most recent first.
| Title | Buyer | CPV | Awarded | Value | Term | Status |
|---|---|---|---|---|---|---|
| NHS England | — | 01 Jun 2026 | £529.1m | 1.9 yrs | pending | |
| SW YORKSHIRE PARTNERSHIP NHS FT, Stores & Distribution | 33651600 | 01 Apr 2026 | £43k | 9 mo | Live | |
| UK HEALTH AND SECURITY AGENCY | 33651600 | 19 Sept 2025 | £1 | 15 mo | Live | |
| NHS England | 33600000 | 01 Mar 2021 | £6.2m | 2 yrs | Closed | |
| Department for Business, Energy & Industrial Strategy | 33651600 | 17 Sept 2020 | £0.5 | 2.3 yrs | Closed | |
| NHS England | 33600000 | 01 May 2020 | £6.1m | 12 mo | Closed | |
| NHS England | 33600000 | 01 Dec 2018 | £3.2m | 12 mo | Closed | |
| Department of Health and Social Care (T&T) | 33651000 | 01 Aug 2018 | — | 3 yrs | Closed | |
| NHS England | 33600000 | 01 Mar 2018 | £17.4m | 2 yrs | Closed | |
| Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency | 33651600 | — | — | — | Live |
Top buyers · 11 buyers · top 3 = 100%
Share of awarded value. Concentration fires above 40% for any single buyer.
Category mix
CPV-division share of last-12m awarded value. Single-category exposure: 100%.
Geography
Distribution of awarded value by buyer region.
Peers
Suppliers with overlapping CPVs & buyers (last 24m). Aventis Pharma Limited T/a Sanofi highlighted.
| Supplier | SME? | Awarded · 24m | Contracts |
|---|---|---|---|
AP Aventis Pharma Limited T/a Sanofi | No | £529.1m | — |
| Yes | £121.0m | 17 | |
| Yes | £117.6m | 16 | |
| Yes | £95.2m | 11 | |
| Yes | £72.5m | 9 | |
| Yes | £71.2m | 18 |
Red flags · 0 active
Automated scan of Companies House status, charges and insolvency records.
Compliance scorecard
Derived from Companies House filings — not a full supplier-assurance check.
Modifications
Variations to awarded contracts logged under Procurement Act 2023 s.74.
No modifications recorded
No published contract variations for this supplier. Modification notices appear here as they are issued under the Procurement Act 2023.
News mentions
UK trade press & nationals, matched to this supplier.
No news mentions found
We haven't matched any recent UK press coverage to this supplier. Mentions appear here automatically as they're published.
Companies House
Live sync — registered details, directors, PSC and SIC codes.
Registered details
- Company no.
- 01535640
- Status
- Active
- Type
- Private limited
- Incorporated
- 18 Dec 1980
- Reg. office
- 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT
- SIC codes
- 46460
- Last accounts
- 31 Dec 2024
- Next accounts due
- 30 Sept 2026
Directors & PSC
- MOHAMED, Walaa Mostafa Abbas Awad — directorAppointed 01 Feb 2026
- MOUSSA, Ahmed Mohamed Moustafa — directorAppointed 01 Feb 2026
- Sanofi-Aventis Uk Holdings Limited — person with significant controlownership of shares 75 to 100 percent · voting rights 75 to 100 percent · right to appoint and remove directors
Financial
Filed accounts from Companies House.
No financial filings on record
Turnover, profit and headcount appear here once audited or micro-entity accounts are filed at Companies House.
Org tree
Group structure and ownership.
Independent. No parent company or subsidiaries recorded at Companies House for this entity.
Social value · 1/5
Commitments mapped to the Government Social Value Model themes. Each is tagged self-reported or from the website.
Extracted automatically from sanofi.com on Jul 2026. Not independently verified — treat as the supplier’s own marketing claims.